These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
193 related articles for article (PubMed ID: 22517558)
21. Development and characterization of novel monoclonal antibodies against tartrate-resistant acid phosphatase 5. Ohashi T; Miura T; Igarashi Y; Kiyokawa I; Sato Y; Sasagawa K; Katagiri K; Mochizuki Y; Tomonaga T; Nomura F; Kojima R; Katayama K Hybridoma (Larchmt); 2006 Dec; 25(6):358-66. PubMed ID: 17203998 [TBL] [Abstract][Full Text] [Related]
22. Serum tartrate-resistant acid phosphatase 5b activity as a prognostic marker of survival in breast cancer with bone metastasis. Wu YY; Janckila AJ; Ku CH; Yu CP; Yu JC; Lee SH; Liu HY; Yam LT; Chao TY BMC Cancer; 2010 Apr; 10():158. PubMed ID: 20416078 [TBL] [Abstract][Full Text] [Related]
23. The association of bone metabolism with bone mineral density, serum sex hormone concentrations, and regular exercise in middle-aged men. Remes T; Väisänen SB; Mahonen A; Huuskonen J; Kröger H; Jurvelin JS; Penttilä IM; Rauramaa R Bone; 2004 Aug; 35(2):439-47. PubMed ID: 15268895 [TBL] [Abstract][Full Text] [Related]
24. Development of immunoassays for serum tartrate-resistant acid phosphatase isoform 5a. Chao TY; Lee SH; Chen MM; Neustadt DH; Chaudhry UA; Yam LT; Janckila AJ Clin Chim Acta; 2005 Sep; 359(1-2):132-40. PubMed ID: 15993395 [TBL] [Abstract][Full Text] [Related]
25. Serum TRACP 5b is a useful marker for monitoring alendronate treatment: comparison with other markers of bone turnover. Nenonen A; Cheng S; Ivaska KK; Alatalo SL; Lehtimäki T; Schmidt-Gayk H; Uusi-Rasi K; Heinonen A; Kannus P; Sievänen H; Vuori I; Väänänen HK; Halleen JM J Bone Miner Res; 2005 Oct; 20(10):1804-12. PubMed ID: 16355501 [TBL] [Abstract][Full Text] [Related]
26. Effects of cadmium on bone microstructure and serum tartrate-resistant acid phosphatase 5b in male rats. Chen X; Zhu G; Shao C; Jin T; Tan M; Gu S; Zhang Y; Xiao H Exp Biol Med (Maywood); 2011 Nov; 236(11):1298-305. PubMed ID: 21908485 [TBL] [Abstract][Full Text] [Related]
27. Tartrate-resistant acid phosphatase isoform 5b (TRACP 5b) as a serum maker for cancer with bone metastasis. Chao TY; Wu YY; Janckila AJ Clin Chim Acta; 2010 Nov; 411(21-22):1553-64. PubMed ID: 20599857 [TBL] [Abstract][Full Text] [Related]
29. [Bone and bone related biochemical examinations. Bone and collagen related metabolites. Tartrate-resistant acid phosphatase (TRACP)]. Mochizuki Y Clin Calcium; 2006 Jun; 16(6):948-55. PubMed ID: 16751690 [TBL] [Abstract][Full Text] [Related]
30. Serum tartrate-resistant acid phosphatase 5b (TRACP 5b) as a marker of skeletal changes in prostate cancer. Salminen E; Ala-Houhala M; Korpela J; Varpula M; Tiitinen SL; Halleen JM; Väänänen HK Acta Oncol; 2005; 44(7):742-7. PubMed ID: 16227166 [TBL] [Abstract][Full Text] [Related]
31. Tartrate-Resistant Acid Phosphatase 5b in Young Patients With Sickle Cell Disease and Trait Siblings: Relation to Vasculopathy and Bone Mineral Density. Mokhtar GM; Tantawy AA; Hamed AA; Adly AA; Ismail EA; Makkeyah SM Clin Appl Thromb Hemost; 2017 Jan; 23(1):64-71. PubMed ID: 26149452 [TBL] [Abstract][Full Text] [Related]
32. Tartrate-resistant acid phosphatase 5B is a specific and sensitive marker of bone resorption. Halleen JM Anticancer Res; 2003; 23(2A):1027-9. PubMed ID: 12820342 [TBL] [Abstract][Full Text] [Related]
33. Assessment of Bone Turnover Biomarkers in Lead-Battery Workers with Long-Term Exposure to Lead. Kalahasthi R; Barman T; Bagepally BS Int J Occup Environ Med; 2020 Jul; 11(3):140-147. PubMed ID: 32683426 [TBL] [Abstract][Full Text] [Related]
34. Tartrate-resistant acid phosphatase (TRACP 5b): a biomarker of bone resorption rate in support of drug development: modification, validation and application of the BoneTRAP kit assay. Wu Y; Lee JW; Uy L; Abosaleem B; Gunn H; Ma M; DeSilva B J Pharm Biomed Anal; 2009 Jul; 49(5):1203-12. PubMed ID: 19356879 [TBL] [Abstract][Full Text] [Related]
35. Potential role of tartrate-resistant acid phosphatase 5b (TRACP 5b) as a surrogate marker of late loosening in patients with total hip arthroplasty: a cohort study. Savarino L; Avnet S; Greco M; Giunti A; Baldini N J Orthop Res; 2010 Jul; 28(7):887-92. PubMed ID: 20063383 [TBL] [Abstract][Full Text] [Related]
36. Clinical performance of immunoreactive tartrate-resistant acid phosphatase isoform 5b as a marker of bone resorption. Hannon RA; Clowes JA; Eagleton AC; Al Hadari A; Eastell R; Blumsohn A Bone; 2004 Jan; 34(1):187-94. PubMed ID: 14751577 [TBL] [Abstract][Full Text] [Related]
37. TRACP 5b and CTX as osteological markers of delayed fracture healing. Moghaddam A; Müller U; Roth HJ; Wentzensen A; Grützner PA; Zimmermann G Injury; 2011 Aug; 42(8):758-64. PubMed ID: 21168135 [TBL] [Abstract][Full Text] [Related]
38. Clinical performance of six different serum tartrate-resistant acid phosphatase assays for monitoring alendronate treatment. Fagerlund KM; Janckila AJ; Ylipahkala H; Tiitinen SL; Nenonen A; Cheng S; Uusi-Rasi K; Yam LT; Väänänen HK; Halleen JM Clin Lab; 2008; 54(9-10):347-54. PubMed ID: 19097492 [TBL] [Abstract][Full Text] [Related]
39. Tartrate-resistant acid phosphatase 5B circulates in human serum in complex with alpha2-macroglobulin and calcium. Ylipahkala H; Halleen JM; Kaija H; Vihko P; Väänänen HK Biochem Biophys Res Commun; 2003 Aug; 308(2):320-4. PubMed ID: 12901871 [TBL] [Abstract][Full Text] [Related]
40. Tartrate-resistant acid phosphatase 5b and its correlations with other markers of bone metabolism in kidney transplant recipients and dialyzed patients. Małyszko J; Małyszko JS; Pawlak K; Wołczyński S; Myśliwiec M Adv Med Sci; 2006; 51():69-72. PubMed ID: 17357281 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]